CD38 and chronic myelogenous leukemia, BCR-ABL1 positive: LSCs in CML are defined as Ph+ CD34+CD38− primitive progenitor cells with a higher capacity to engraft in immunocompromised mice with respect to normal CD34+ cells, stem-cell properties such as quiescence and self-renewal, genomic instability, and resistant to apoptosis.